HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Lin, H. C. Articles by Chen, J. H. Search for Related Content PubMed PubMed Citation Articles by Lin, H. C. Articles by Chen, J. H.

NEUROREGULATION AND MOTILITY

Slowing intestinal transit by PYY depends on serotonergic and opioid pathways

Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033

Submitted 1 July 2003 ; accepted in final form 17 November 2003

Slowing of intestinal transit by fat is abolished by immunoneutralization of peptide YY (PYY), demonstrating a key role for this gut peptide. How PYY slows intestinal transit is not known. We tested the hypothesis that the slowing of intestinal transit by PYY may depend on an ondansetron-sensitive serotonergic pathway and a naloxone-sensitive opioid pathway. In a fistulated dog model, occluding Foley catheters were used to compartmentalize the small intestine into proximal (between fistulas) and distal (beyond midgut fistula) half of gut. Buffer (pH 7.0) was perfused into both proximal and distal gut, and PYY was delivered intravenously. Ondansetron or naloxone was mixed with buffer and delivered into either the proximal or distal half of gut. Intestinal transit was measured across the proximal half of the gut. The slowing of intestinal transit by PYY was abolished when either ondansetron or naloxone was delivered into the proximal, but not the distal gut, to localize the two pathways to the efferent limb of the slowing response. In addition, 5-HT slows intestinal transit with marker recovery decreased from 76.2 ± 3.6% (control) to 33.5 ± 2.4% (5-HT) (P < 0.0001) but was reversed by naloxone delivered into the proximal gut with marker recovery increased to 79.9 ± 7.2% (P < 0.0005). We conclude that the slowing of intestinal transit by PYY depends on serotonergic neurotransmission via an opioid pathway.

ileal brake; intestinal motility; 5-HT; enteric nervous system

This article has been cited by other articles:

				J. R. Grider and B. E. Piland The peristaltic reflex induced by short-chain fatty acids is mediated by sequential release of 5-HT and neuronal CGRP but not BDNF Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G429 - G437. [Abstract] [Full Text] [PDF]

				M. Pimentel, H. C. Lin, P. Enayati, B. van den Burg, H.-R. Lee, J. H. Chen, S. Park, Y. Kong, and J. Conklin Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1089 - G1095. [Abstract] [Full Text] [PDF]

				P. K. Chelikani, A. C. Haver, J. R. Reeve Jr., D. A. Keire, and R. D. Reidelberger Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R298 - R305. [Abstract] [Full Text] [PDF]